Patent · US Active

PCV/mycoplasma hyopneumoniae/PRRS combination vaccine

US9125886B2 · kind B2 · utility

10Cited by

45References

21Claims

0Family size

Assignee

ZOETIS SERVICES LLC · US

Inventors

Gregory Paul Nitzel · Paw Paw, US
Jeffrey E. Galvin · Lincoln, US
John Keith Garrett · North Wilkesboro, US
James R. Kulawik, II · Lincoln, US
Tracy L. Ricker · Portage, US
Megan Marie Smutzer · Kalamazoo, US

Key dates

Filing date	Mar 26, 2013
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Mar 26, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/10034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a trivalent immunogenic composition including a soluble portion of a Mycoplasma hyopneumoniae (M.hyo) whole cell preparation; a porcine circovirus type 2 (PCV2) antigen; and a PRRS virus antigen, wherein the soluble portion of the M. hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.